Review article: Gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 11, 2015, Pages 1104-1115

  Peters, S L ^a   Muir, J G ^a   Gibson, P R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NERVOUS SYSTEM; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GUT DIRECTED HYPNOTHERAPY; HUMAN; HYPNOSIS; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE INNERVATION; INTESTINE MOTILITY; IRRITABLE COLON; META ANALYSIS (TOPIC); NEUROTRANSMISSION; NOCICEPTION; PATIENT SAFETY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF CONCEPT; SIGNAL DETECTION; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT INDICATION; BRAIN; COLITIS, ULCERATIVE; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; METABOLISM; MULTIMODALITY CANCER THERAPY; PROCEDURES; PSYCHOLOGY;

BRAIN; COLITIS, ULCERATIVE; COMBINED MODALITY THERAPY; HUMANS; HYPNOSIS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME;

EID: 84929134084     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13202     Document Type: Review

References (68)

1. Hillilä M, Färkkilä M,. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004; 20: 339-45.
2. Hungin A, Whorwell P, Tack J, Mearin F,. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17: 643-50.
3. Ong D, Mitchell S, Barrett J, et al,. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1366-73.
4. Halmos EP,. Dietary FODMAPs and the Pathogenesis of Functional Gastrointestinal Symptoms. Monash University, 2013.
5. Videlock EJ, Chang L,. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol Clin North Am 2007; 36: 665-85.
6. Camilleri M, Williams DE,. Economic burden of irritable bowel syndrome. Pharmacoeconomics 2000; 17: 331-8.
7. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML,. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325-33.
8. Halpin SJ, Ford AC,. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 1474-82.
9. Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES,. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97: 389-96.
10. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ,. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006; 12: 38-46.
11. Barratt SM, Leeds JS, Robinson K, et al,. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011; 23: 159-65.
12. Minderhoud IM, Oldenburg B, Wismeijer JA, Henegouwen GPVB, Smout AJ,. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004; 49: 469-74.
13. Jones MP, Wessinger S, Crowell MD,. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. Clin Gastroenterol Hepatol 2006; 4: 474-81.
14. Asthana A, Gibson P,. Irritable Bowel Sydrome in Inflammatory Bowel Disease, and Psychological Implications. Psychological Aspects of Inflammatory Bowel Disease. East Sussex: Routledge, in press.
15. Mayer EA, Tillisch K,. The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011; 62: 381-96.
16. Koloski N, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley N,. The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012; 61: 1284-90.
17. Gonsalkorale WM,. Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome. Int J Clin Exp Hypn 2006; 54: 27-50.
18. Ford AC, Quigley EM, Lacy BE, et al,. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2014; 109: 1350-65.
19. Whorwell P, Prior A, Faragher E,. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984; 324: 1232-4.
20. Galovski T, Blanchard E,. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback 1998; 23: 219-32.
21. Palsson OS, Turner MJ, Johnson DA, Burnett CK, Whitehead WE,. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002; 47: 2605-14.
22. Lindfors P, Unge P, Arvidsson P, et al,. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 2011; 107: 276-85.
23. Roberts L, Wilson S, Singh S, Roalfe A, Greenfield S,. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Br J Gen Pract 2006; 56: 115-21.
24. Moser G, Trägner S, Gajowniczek EE, et al,. Long-term success of gut-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2013; 108: 602-9.
25. Simrén M, Ringström G, Björnsson ES, Abrahamsson H,. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004; 66: 233-8.
26. Keefer L, Taft T, Kiebles J, Martinovich Z, Barrett T, Palsson O,. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 2013; 38: 761-71.
27. Keefer L, Kiebles JL, Martinovich Z, Cohen E, Van Denburg A, Barrett TA,. Behavioral interventions may prolong remission in patients with inflammatory bowel disease. Behav Res Ther 2011; 49: 145-50.
28. Moser G, Maeir-Dobersberger T, Vogelsang H, Lochs H,. Inflammatory bowel disease: patient's beliefs about the etiology of their disease-a controlled study. Psychosom Med 1993; 55: 131.
29. Lindfors P, Unge P, Nyhlin H, et al,. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scand J Gastroenterol 2012; 47: 414-21.
30. Smith GD,. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome. J Clin Nurs 2006; 15: 678-84.
31. Palsson OS, Turner MJ, Whitehead WE,. Hypnosis home treatment for irritable bowel syndrome: a pilot study. Int J Clin Exp Hypn 2006; 54: 85-99.
32. Al Sughayir M,. Hypnotherapy for irritable bowel syndrome in Saudi Arabian patients. East Mediterr Health J 2007; 13: 301-7.
33. Gonsalkorale W, Miller V, Afzal A, Whorwell P,. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003; 52: 1623-9.
34. Gonsalkorale WM, Houghton LA, Whorwell PJ,. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002; 97: 954-61.
35. Gonsalkorale WM, Toner BB, Whorwell PJ,. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004; 56: 271-8.
36. Lea R, Houghton L, Calvert E, et al,. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 635-42.
37. Houghton L, Heyman D, Whorwell P,. Symptomatology, quality of life and economic features of irritable bowel syndrome-the effect of hypnotherapy. Aliment Pharmacol Ther 1996; 10: 91-5.
38. Prior A, Colgan S, Whorwell P,. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990; 31: 896-8.
39. Whorwell P, Prior A, Colgan S,. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987; 28: 423-5.
40. Taylor EE, Read NW, Hills HM,. Combined group cognitive-behaviour therapy and hypnotherapy in the management of the irritable bowel syndrome: the feasibility of clinical provision. Behav Cogn Psychother 2004; 32: 99-106.
41. Vidakovic-Vukic M,. Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam. Scand J Gastroenterol 1999; 34: 49-51.
42. Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ,. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther 2015; 41: 844-55.
43. Galovski TE, Blanchard EB,. Hypnotherapy and refractory irritable bowel syndrome: a single case study. Am J Clin Hypn 2002; 45: 31-7.
44. Walters VJ, Oakley DA,. Hypnotic imagery as an adjunct to therapy for irritable bowel syndrome: an experimental case report. Contemp Hypn 2006; 23: 141-9.
45. Zimmerman J,. Cleaning up the river: a metaphor for functional digestive disorders. Am J Clin Hypn 2003; 45: 353-9.
46. Forbes A, MacAuley S, Chiotakakou-Faliakou E,. Hypnotherapy and therapeutic audiotape: effective in previously unsuccessfully treated irritable bowel syndrome? Int J Colorectal Dis 2000; 15: 328-34.
47. Barabasz A, Barabasz M,. Effects of tailored and manualized hypnotic inductions for complicated irritable bowel syndrome patients. Int J Clin Exp Hypn 2006; 54: 100-12.
48. Harvey R, Gunary R, Hinton R, Barry R,. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989; 333: 424-5.
49. Vlieger AM, van den Berg MM, Menko-Frankenhuis C, Bongers ME, Tromp E, Benninga M,. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2009; 105: 213-8.
50. Whorwell P, Houghton L, Taylor E, Maxton D,. Physiological effects of emotion: assessment via hypnosis. Lancet 1992; 340: 69-72.
51. Carruthers HR, Miller V, Morris J, Evans R, Tarrier N, Whorwell PJ,. Using art to help understand the imagery of irritable bowel syndrome and its response to hypnotherapy. Int J Clin Exp Hypn 2009; 57: 162-73.
52. Carruthers HR, Morris J, Tarrier N, Whorwell PJ,. Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome. BMC Complement Altern Med 2010; 10: 75.
53. Vlieger AM, Rutten JM, Govers AM, Frankenhuis C, Benninga MA,. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2012; 107: 627-31.
54. Simrén M,. Hypnosis for irritable bowel syndrome: the quest for the mechanism of action. Int J Clin Exp Hypn 2006; 54: 65-84.
55. Houghton L, Larder S, Lee R, et al,. Gut focused hypnotherapy normalises rectal hypersensitivity in patients with irritable bowel syndrome (IBS). Gastroenterology 1999; 116: A1009-A.
56. Gruzelier J, Smith F, Nagy A, Henderson D,. Cellular and humoral immunity, mood and exam stress: the influences of self-hypnosis and personality predictors. Int J Psychophysiol 2001; 42: 55-71.
57. Kiecolt-Glaser JK, Marucha PT, Atkinson C, Glaser R,. Hypnosis as a modulator of cellular immune dysregulation during acute stress. J Consult Clin Psychol 2001; 69: 674.
58. Mawdsley JE, Jenkins DG, Macey MG, Langmead L, Rampton DS,. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 2008; 103: 1460-9.
59. Mertz H,. Altered CNS processing of visceral pain in IBS. In:, Camilleri M, Spiller RC, eds. Irritable bowel syndrome: Diagnosis and treatment. London, United Kingdom: WB Saunders, 2002; 55-68.
60. Lowén M, Mayer E, Sjöberg M, et al,. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther 2013; 37: 1184-97.
61. Yapko MD,. Trancework: An Introduction to the Practice of Clinical Hypnosis. 4th ed. New York: Routledge, 2012.
62. Shor RE, Orne EC, Press CP,. Harvard Group Scale of Hypnotic Susceptibility: Form A. Stanford University: Consulting Psychologists Press, 1962.
63. Weitzenhoffer AM, Hilgard ER,. Stanford Hypnotic Susceptibility Scale, Form C. Palo Alto, CA: Consulting Psychologists Press, 1962.
64. Boot WR, Simons DJ, Stothart C, Stutts C,. The pervasive problem with placebos in psychology why active control groups are not sufficient to rule out placebo effects. Perspect Psychol Sci 2013; 8: 445-54.
65. Tuck CJ, Muir JG, Barrett JS, Gibson PR,. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2014; 8: 819-34.
66. Halmos E, Power V, Shepherd S, Gibson P, Muir J,. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67-75 e5.
67. Patel SM, Stason WB, Legedza A, et al,. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005; 17: 332-40.
68. Gerson CD, Gerson J, Gerson M-J,. Group hypnotherapy for irritable bowel syndrome with long-term follow-up. Int J Clin Exp Hypn 2013; 61: 38-54.